Hengrui Pharma: Proxy Form for 2025 Annual General Meeting Issued

核心變化恒瑞医药发布2025年股东大会代理投票表格,股东可就公司决策进行投票。

Hengrui Pharmaceuticals (恒瑞医药)·中國Leadership & Governance
官方来源CNINFO (巨潮资讯网)Chinese原文cninfo.com.cn·
收錄於 Mar 25, 2026 23:39 (1d ago)
·
LinkedInX
Source ContextCNINFO (巨潮资讯网)

Hengrui Pharmaceuticals has released the proxy appointment form for its 2025 Annual General Meeting. This document is crucial for shareholders to exercise their voting rights and participate in key corporate decisions.

阅读完整原文cninfo.com.cn
来源层级:Official
分类:规范
收录时间:Mar 25, 2026 23:39
日期可信度:提取
基于企业官方来源。SigFact 从经验证的企业公告中提取并结构化信号。

Sign in to save notes on signals.

登录